Literature DB >> 31315034

Inflammation and Cancer: Triggers, Mechanisms, and Consequences.

Florian R Greten1, Sergei I Grivennikov2.   

Abstract

Inflammation predisposes to the development of cancer and promotes all stages of tumorigenesis. Cancer cells, as well as surrounding stromal and inflammatory cells, engage in well-orchestrated reciprocal interactions to form an inflammatory tumor microenvironment (TME). Cells within the TME are highly plastic, continuously changing their phenotypic and functional characteristics. Here, we review the origins of inflammation in tumors, and the mechanisms whereby inflammation drives tumor initiation, growth, progression, and metastasis. We discuss how tumor-promoting inflammation closely resembles inflammatory processes typically found during development, immunity, maintenance of tissue homeostasis, or tissue repair and illuminate the distinctions between tissue-protective and pro-tumorigenic inflammation, including spatiotemporal considerations. Defining the cornerstone rules of engagement governing molecular and cellular mechanisms of tumor-promoting inflammation will be essential for further development of anti-cancer therapies.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer; cell plasticity; cytokine; inflammation; mechanisms; metastasis; tumor microenvironment; tumor progression

Year:  2019        PMID: 31315034      PMCID: PMC6831096          DOI: 10.1016/j.immuni.2019.06.025

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  169 in total

1.  Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.

Authors:  Jean Albrengues; Mario A Shields; David Ng; Chun Gwon Park; Alexandra Ambrico; Morgan E Poindexter; Priya Upadhyay; Dale L Uyeminami; Arnaud Pommier; Victoria Küttner; Emilis Bružas; Laura Maiorino; Carmelita Bautista; Ellese M Carmona; Phyllis A Gimotty; Douglas T Fearon; Kenneth Chang; Scott K Lyons; Kent E Pinkerton; Lloyd C Trotman; Michael S Goldberg; Johannes T-H Yeh; Mikala Egeblad
Journal:  Science       Date:  2018-09-28       Impact factor: 47.728

2.  Connecting Cancer to Its Causes Requires Incorporation of Effects on Tissue Microenvironments.

Authors:  James DeGregori
Journal:  Cancer Res       Date:  2017-07-28       Impact factor: 12.701

Review 3.  Necroptosis in development, inflammation and disease.

Authors:  Ricardo Weinlich; Andrew Oberst; Helen M Beere; Douglas R Green
Journal:  Nat Rev Mol Cell Biol       Date:  2016-12-21       Impact factor: 94.444

4.  RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma.

Authors:  Adeline R Lam; Nina Le Bert; David H Raulet; Stephan Gasser; Samantha Sw Ho; Yu J Shen; Li Fm Tang; Gordon M Xiong; John L Croxford; Christine X Koo; Ken J Ishii; Shizuo Akira
Journal:  Cancer Res       Date:  2014-03-03       Impact factor: 12.701

Review 5.  NK cell self tolerance, responsiveness and missing self recognition.

Authors:  Nataliya Shifrin; David H Raulet; Michele Ardolino
Journal:  Semin Immunol       Date:  2014-03-12       Impact factor: 11.130

Review 6.  Targeting tumor associated macrophages: The new challenge for nanomedicine.

Authors:  Fernando Torres Andón; Elisabeth Digifico; Akihiro Maeda; Marco Erreni; Alberto Mantovani; María José Alonso; Paola Allavena
Journal:  Semin Immunol       Date:  2017-09-21       Impact factor: 11.130

Review 7.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

8.  Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.

Authors:  Evgeniy B Eruslanov; Pratik S Bhojnagarwala; Jon G Quatromoni; Tom Li Stephen; Anjana Ranganathan; Charuhas Deshpande; Tatiana Akimova; Anil Vachani; Leslie Litzky; Wayne W Hancock; José R Conejo-Garcia; Michael Feldman; Steven M Albelda; Sunil Singhal
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

9.  Fatty acid transport protein 2 reprograms neutrophils in cancer.

Authors:  Filippo Veglia; Vladimir A Tyurin; Maria Blasi; Alessandra De Leo; Andrew V Kossenkov; Laxminarasimha Donthireddy; Tsun Ki Jerrick To; Zach Schug; Subhasree Basu; Fang Wang; Emanuela Ricciotti; Concetta DiRusso; Maureen E Murphy; Robert H Vonderheide; Paul M Lieberman; Charles Mulligan; Brian Nam; Neil Hockstein; Gregory Masters; Michael Guarino; Cindy Lin; Yulia Nefedova; Paul Black; Valerian E Kagan; Dmitry I Gabrilovich
Journal:  Nature       Date:  2019-04-17       Impact factor: 49.962

10.  Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Authors:  Nicola Aceto; Aditya Bardia; David T Miyamoto; Maria C Donaldson; Ben S Wittner; Joel A Spencer; Min Yu; Adam Pely; Amanda Engstrom; Huili Zhu; Brian W Brannigan; Ravi Kapur; Shannon L Stott; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Charles P Lin; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

View more
  534 in total

1.  Defective apoptotic cell contractility provokes sterile inflammation, leading to liver damage and tumour suppression.

Authors:  Linda Julian; Gregory Naylor; Grant R Wickman; Nicola Rath; Giovanni Castino; David Stevenson; Sheila Bryson; June Munro; Lynn McGarry; Margaret Mullin; Alistair Rice; Armandodel Del Río Hernández; Michael F Olson
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

Review 2.  MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment.

Authors:  Donald W Kufe
Journal:  Carcinogenesis       Date:  2020-09-24       Impact factor: 4.944

3.  MUC1-C drives stemness in progression of colitis to colorectal cancer.

Authors:  Wei Li; Ning Zhang; Caining Jin; Mark D Long; Hasan Rajabi; Yota Yasumizu; Atsushi Fushimi; Nami Yamashita; Masayuki Hagiwara; Rongbin Zheng; Jin Wang; Ling Kui; Harpal Singh; Surender Kharbanda; Qiang Hu; Song Liu; Donald Kufe
Journal:  JCI Insight       Date:  2020-06-18

4.  Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies.

Authors:  Gabriella D'Orazi; Marco Cordani; Mara Cirone
Journal:  Cell Mol Life Sci       Date:  2020-10-17       Impact factor: 9.261

Review 5.  The duality of human oncoproteins: drivers of cancer and congenital disorders.

Authors:  Pau Castel; Katherine A Rauen; Frank McCormick
Journal:  Nat Rev Cancer       Date:  2020-04-27       Impact factor: 60.716

6.  Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential.

Authors:  Joo-Hyung Lee; Feng Xiong; Wenbo Li
Journal:  RNA Biol       Date:  2020-01-19       Impact factor: 4.652

Review 7.  Physical traits of cancer.

Authors:  Hadi T Nia; Lance L Munn; Rakesh K Jain
Journal:  Science       Date:  2020-10-30       Impact factor: 47.728

8.  Intestinal epithelium-derived BATF3 promotes colitis-associated colon cancer through facilitating CXCL5-mediated neutrophils recruitment.

Authors:  Y Lin; L Cheng; Y Liu; Y Wang; Q Wang; H L Wang; G Shi; J S Li; Q N Wang; Q M Yang; S Chen; X L Su; Y Yang; M Jiang; X Hu; P Fan; C Fang; Z G Zhou; L Dai; H X Deng
Journal:  Mucosal Immunol       Date:  2020-05-28       Impact factor: 7.313

Review 9.  Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype.

Authors:  Abigail C Cornwell; Michael E Feigin
Journal:  Trends Pharmacol Sci       Date:  2020-10-22       Impact factor: 14.819

10.  Systemic immune responses are associated with molecular characteristics of circulating tumor cells in head and neck squamous cell carcinoma.

Authors:  Hiroe Tada; Yurino Nagata; Hideyuki Takahashi; Toshiyuki Matsuyama; Shota Ida; Ikko Mito; Kazuaki Chikamatsu
Journal:  Mol Clin Oncol       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.